AUA: Kidney Transplants From COVID-19-Infected Donors Are Safe
MONDAY, May 16, 2022 (HealthDay News) — Transplantation of kidneys from COVID-19-positive donors is safe, with outcomes comparable to kidneys from noninfected donors, according to a study presented at the annual meeting of the American Urological Association, held from May 13 to 16 in New Orleans.
Yi-Chia Lin, M.D., from the Cleveland Clinic, and colleagues shared early outcomes from 55 recipients of transplant kidneys from 34 COVID-19-positive deceased donors from February to October 2021.
The researchers reported that the mean donor age was 34 years with a mean kidney donor profile index of 36.9 percent. The patient cohort included 36 male recipients and 19 female recipients (mean age among all recipients, 51.2 years). Two-thirds of recipients were dialysis-dependent, and a similar proportion (67.3 percent) had received both COVID-19 vaccine doses. Roughly one in five recipients experienced delayed graft function (19.6 percent). After surgery, no recipients tested positive for COVID-19. All kidney allografts were functioning at a mean follow-up of 3.5 months, with a mean serum creatinine of 1.6 mg/dL. At 1.5 months posttransplant, one patient underwent allograft nephrectomy due to Pseudomonas aeruginosa vascular infection.
People are also reading…
“Transplantation of kidneys from COVID-19 positive donors is safe,” the authors write. “Outcomes are comparable to kidneys from regular donors.”
Originally published on consumer.healthday.com, part of the TownNews Content Exchange.
For all the latest Health News Click Here
For the latest news and updates, follow us on Google News.